Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN

ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE

Standard Dose
500MG;100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 077196 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE Form and strength TABLET;ORAL - 500MG;100MG Sponsor WATSON LABS FLORIDA Submission history Latest submission status date: 2005-06-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 077196 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE Form and strength TABLET;ORAL - 500MG;100MG Sponsor WATSON LABS FLORIDA Submission history Latest submission status date: 2005-06-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.